Geisinger And Medacta Pilot Guarantees Coverage Of Hip Replacements For Life
Executive Summary
Geisinger Health has teamed up with Swiss-based device-maker Medacta International in a pilot program guaranteeing lifetime coverage of hip replacement costs for Geisenger patients.
You may also be interested in...
Value-Based Purchasing, Bundling Require New Types Of Product Pitches
Device makers may need to change the way they pitch their products as providers make the move to a more stringent focus on value and to more integrated approaches to episodes of care, speakers stressed at the AdvaMed 2009 MedTech conference earlier this month
QUOTED. 6 May 2020. Paul Diaz.
Myriad has sold several business units as it narrows its focus to oncology, women's health and mental health diagnostics. CEO Paul Diaz says the moves will allow the company to be a market leader.
After ODAC: The State Of Accelerated Approval At The US FDA
US FDA’s Accelerated Approval process has always been a deceptively simple idea. After a three-day public review of ‘dangling’ applications, the underlying complexity remains.